Aspira Women's Health Inc.
AWHL· OTC
Released Mar 26, 2020, after the close
10-K filed Apr 7, 2020, 98 days after period end · 0000926617-20-000015
derived · Computed from the longer spans the company filed.
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures | Q4 2017dderived from reported figures | Q4 2016dderived from reported figures |
|---|---|---|---|---|
| Revenue | $1.31M | $922.00K | $798.00K | $805.00K |
| Net Income | -$3.39M |
Aspira Women's Health Inc. · CIK 926617 · Engraved from SEC EDGAR
| -$2.82M |
| -$2.96M |
| -$2.85M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.